Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Gains from Investment Securities (2016 - 2026)

Ani Pharmaceuticals' Gains from Investment Securities history spans 15 years, with the latest figure at $1.4 million for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 73.87% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.6 million, a 24.2% increase, with the full-year FY2025 number at $6.6 million, up 24.2% from a year prior.
  • Gains from Investment Securities hit $1.4 million in Q4 2025 for Ani Pharmaceuticals, down from $5.2 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for ANIP hit a ceiling of $5.3 million in Q1 2024 and a floor of -$5.3 million in Q3 2024.
  • Historically, Gains from Investment Securities has averaged $1.3 million across 5 years, with a median of $777000.0 in 2021.
  • The widest YoY moves for Gains from Investment Securities: up 12059.46% in 2023, down 281.7% in 2023.
  • Tracing ANIP's Gains from Investment Securities over 5 years: stood at $241000.0 in 2021, then surged by 927.39% to $2.5 million in 2022, then tumbled by 281.7% to -$4.5 million in 2023, then soared by 218.85% to $5.3 million in 2024, then tumbled by 73.87% to $1.4 million in 2025.
  • Business Quant data shows Gains from Investment Securities for ANIP at $1.4 million in Q4 2025, $5.2 million in Q3 2025, and $5.3 million in Q4 2024.